skip to Main Content
Accelerating Medicines Partnership
Rheumatoid Arthritis and Lupus

The Accelerating Medicines Partnership is aimed at improving our understanding of disease pathways and facilitate better selection of targets for treatment

RECENT NEWS

MASSIVE NIH-INDUSTRY PROJECT OPENS PORTAL TO TARGET VALIDATION

February 27, 2019

Read more

ACCELERATING MEDICINES PARTNERSHIP EXTENDS THE RA AND LUPUS PROGRAM TO MAXIMIZE THE BENEFITS OF EMERGING TECHNOLOGIES TO ADVANCE NEW THERAPIES

December 14, 2018

Read more

INSIGHTS FROM COMPARISON OF THE RENAL AND SKIN SINGLE CELL TRANSCRIPTOMES IN LUPUS NEPHRITIS

August 1, 2018

Read more

Rheumatoid Arthritis and Lupus
Funded By
Back To Top